Building Durability in Rare Disease Care With PANTHERx Rare

Advertisement
Feature|Videos|July 7, 2026

Building Durability in Rare Disease Care With PANTHERx Rare

Author(s)Bansi Nagji, CEO, PANTHERx Rare

Key Takeaways

Understand why scientific innovation targets rare and orphan disease treatments
Learn what distinguishes a rare-only pharmacy model from traditional specialty pharmacy approaches
Recognize why launch is only the starting point for long-term therapy success

Bansi Nagji discusses the shifting science behind rare and orphan drug development, including what it takes for therapies to succeed well beyond launch

Bansi Nagji, CEO of PANTHERx Rare, explores how innovation is increasingly directed toward rare and orphan diseases, driven by targeted incentives, tax breaks, and a more streamlined FDA approval pathway. Nagji covers the operational realities that set rare disease therapies apart, including cold chain logistics, weight-based titration regimens, and the intensive patient interactions required before a single prescription is even filled. Learn why launch marks the beginning of a therapy’s journey rather than its conclusion, and why ongoing work is necessary for payer access and long-term adherence.

What's Hot

Comedian Nam Hyo-na loses nearly 30kg with obesity treatment drug… “It must never be used for cosmetic purposes” [New Story]

St. Mary’s Residential Community opens wellness gym for residents with developmental disabilities

What to eat while taking a GLP

Building Durability in Rare Disease Care With PANTHERx Rare

Discovering How Stem T Cells Sustain Immune Defenses During Chronic Disease – Weill Cornell Medicine

Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up

The Jackson Laboratory, with the Broad Institute and Partners, Selected for ARPA-H THRIVE Award to Advance Gene Editing Platform for Pediatric Epilepsies and Rare CNS Diseases

Comedian Nam Hyo-na loses nearly 30kg with obesity treatment drug… “It must never be used for cosmetic purposes” [New Story]

St. Mary’s Residential Community opens wellness gym for residents with developmental disabilities

What to eat while taking a GLP

Gov. Green Signs Legislation to Expand Access to Healthcare and Relieve Medical Debt

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

Comedian Nam Hyo-na loses nearly 30kg with obesity treatment drug… “It must never be used for cosmetic purposes” [New Story]

St. Mary’s Residential Community opens wellness gym for residents with developmental disabilities

What to eat while taking a GLP

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Building Durability in Rare Disease Care With PANTHERx Rare

Building Durability in Rare Disease Care With PANTHERx Rare

Key Takeaways

Related Content

A Biopharma Perspective on What’s Next in Access & Affordability

Hospital Pharmacy and Supply Chain Leaders Want to Be Heard: Are you Ready to Listen?

From Launch to Loss of Exclusivity- Reducing Access and Affordability Barriers Across the Brand Lifecycle

Smarter, Faster, Bolder: AI’s New Role in Pharma Strategy

Rethinking Go-to-Market Strategy with Innovation in a Patient-Centric Era

Trending on Pharmaceutical Commerce

What Trutakna’s Approval Means for Specialty Launches

The Evolution and Impact of Patient Support Services: A Strategic Framework

How Real-Time DTP Data Are Rewriting Pharma’s Commercial Playbook

What Makes Patient Support Programs Work, and What Doesn’t

Building Durability in Rare Disease Care With PANTHERx Rare

Related Posts